Gene therapies and COVID-19 vaccines: a necessary discussion in relation with viral vector-based approaches

The COVID-19 pandemic is adding an unanticipated concern for those affected by genetic diseases. Most of the new treatment achievements for these patients are made possible as a result of advances in viral-based products. Among them, adenoviruses (AdV) and especially adeno-associated viruses (AAV) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aledo-Serrano, Angel, Gil-Nagel, Antonio, Isla, Julian, Mingorance, Ana, Mendez-Hermida, Fernando, Hernandez-Alcoceba, Ruben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284696/
https://www.ncbi.nlm.nih.gov/pubmed/34271959
http://dx.doi.org/10.1186/s13023-021-01958-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284696/
https://www.ncbi.nlm.nih.gov/pubmed/34271959
http://dx.doi.org/10.1186/s13023-021-01958-3

Ejemplares similares